Chemokine Receptors
暂无分享,去创建一个
[1] J. Tregoning,et al. Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection , 2005, Clinical Microbiology Reviews.
[2] Albert Zlotnik,et al. Pharmacological Characterization of CXC Chemokine Receptor 3 Ligands and a Small Molecule Antagonist , 2005, Journal of Pharmacology and Experimental Therapeutics.
[3] J. Wityak,et al. Identification of chemokine receptor CCR4 antagonist. , 2005, Bioorganic & medicinal chemistry letters.
[4] C. Brightling,et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. , 2005, American journal of respiratory and critical care medicine.
[5] M. Schwarz,et al. Multi-faceted strategies to combat disease by interference with the chemokine system. , 2005, Trends in immunology.
[6] M. Wymann,et al. Phosphoinositide 3-kinase in disease: timing, location, and scaffolding. , 2005, Current opinion in cell biology.
[7] D. d'Ambrosio. Targeting chemoattractant receptors in allergic inflammation. , 2005, Current drug targets. Inflammation and allergy.
[8] Antonio Alcami,et al. The chemokine receptor D6 limits the inflammatory response in vivo , 2005, Nature Immunology.
[9] G. Trainor,et al. Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency. , 2005, Journal of medicinal chemistry.
[10] I. Tillie‐Leblond,et al. Inflammatory events in severe acute asthma , 2005, Allergy.
[11] Aaron S. Anderson,et al. Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists. , 2004, Bioorganic & medicinal chemistry letters.
[12] M. Mack,et al. Interference with Heparin Binding and Oligomerization Creates a Novel Anti-Inflammatory Strategy Targeting the Chemokine System , 2004, The Journal of Immunology.
[13] C. Ding,et al. Bertilimumab Cambridge Antibody Technology Group. , 2004, Current opinion in investigational drugs.
[14] S. Orkin,et al. A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.
[15] S. Durham,et al. CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge , 2004, European Respiratory Journal.
[16] W. Busse,et al. Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma. , 2004, American journal of respiratory and critical care medicine.
[17] N. Lukacs,et al. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. , 2004, The Journal of infectious diseases.
[18] R. Offord,et al. Inhibition of Airway Inflammation by Amino-Terminally Modified RANTES/CC Chemokine Ligand 5 Analogues Is Not Mediated through CCR3 , 2003, The Journal of Immunology.
[19] M. Liu,et al. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. , 2003, The Journal of allergy and clinical immunology.
[20] S. Phipps,et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. , 2003, The Journal of clinical investigation.
[21] J. Boehm,et al. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases , 2003, Nature Reviews Drug Discovery.
[22] P. Finan,et al. Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents. , 2003, Current opinion in pharmacology (Print).
[23] A. Gruber,et al. CXCR2 Regulates Respiratory Syncytial Virus-Induced Airway Hyperreactivity and Mucus Overproduction1 , 2003, The Journal of Immunology.
[24] C. Martínez-A,et al. Absence of CCR8 Does Not Impair the Response to Ovalbumin-Induced Allergic Airway Disease 1 , 2003, The Journal of Immunology.
[25] W. Henderson,et al. CCR8 Is Not Essential for the Development of Inflammation in a Mouse Model of Allergic Airway Disease , 2003, The Journal of Immunology.
[26] J. Mudgett,et al. Functional Expression and Characterization of Macaque C-C Chemokine Receptor 3 (CCR3) and Generation of Potent Antagonistic Anti-macaque CCR3 Monoclonal Antibodies* , 2002, The Journal of Biological Chemistry.
[27] R. Förster,et al. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. , 2002, Blood.
[28] A. Roshak,et al. Small-molecule inhibitors of NF-κB for the treatment of inflammatory joint disease , 2002 .
[29] I. Pavord,et al. Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.
[30] Dominique Schols,et al. AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. , 2002, The American journal of pathology.
[31] C. Hogaboam,et al. CXCR2 Is Necessary for the Development and Persistence of Chronic Fungal Asthma in Mice1 , 2002, The Journal of Immunology.
[32] Clare Lloyd,et al. Chemokines in allergic lung inflammation , 2002, Immunology.
[33] T. Huynh,et al. RANTES Activates Jak2 and Jak3 to Regulate Engagement of Multiple Signaling Pathways in T Cells* , 2001, The Journal of Biological Chemistry.
[34] Tong-Yuan Yang,et al. Aberrant in Vivo T Helper Type 2 Cell Response and Impaired Eosinophil Recruitment in Cc Chemokine Receptor 8 Knockout Mice , 2001, The Journal of experimental medicine.
[35] M. Thelen,et al. Dancing to the tune of chemokines , 2001, Nature Immunology.
[36] P. Finan,et al. Phosphoinositide 3-kinase γ: a key modulator in inflammation and allergy , 2001 .
[37] I. Homma,et al. Intervention of Thymus and Activation-Regulated Chemokine Attenuates the Development of Allergic Airway Inflammation and Hyperresponsiveness in Mice1 , 2001, The Journal of Immunology.
[38] K. Chung,et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.
[39] J. Gutiérrez-Ramos,et al. Non‐redundant functional groups of chemokines operate in a coordinate manner during the inflammatory response in the lung , 2000, Immunological reviews.
[40] A. Alcamí,et al. Viral mechanisms of immune evasion , 2000, Molecular Medicine Today.
[41] M. Peck,et al. A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3 , 2000, The Journal of Biological Chemistry.
[42] A. Peled,et al. Critical Involvement of the Chemotactic Axis CXCR4/Stromal Cell-Derived Factor-1α in the Inflammatory Component of Allergic Airway Disease , 2000, The Journal of Immunology.
[43] Yolande Chvatchko,et al. A Key Role for Cc Chemokine Receptor 4 in Lipopolysaccharide-Induced Endotoxic Shock , 2000, The Journal of experimental medicine.
[44] M. Loda,et al. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1 , 2000, Nature.
[45] H. Brühl,et al. Differential Activation of CC Chemokine Receptors by AOP-RANTES* , 2000, The Journal of Biological Chemistry.
[46] P. Allavena,et al. Chemokine receptors: interaction with HIV-1 and viral-encoded chemokines. , 2000, Pharmaceutica acta Helvetiae.
[47] A. Zlotnik,et al. Chemokines in allergy. , 1999, Current opinion in immunology.
[48] C. Meisel,et al. Crucial Role of the Interleukin 1 Receptor Family Member T1/St2 in T Helper Cell Type 2–Mediated Lung Mucosal Immune Responses , 1999, The Journal of experimental medicine.
[49] P. Askenase,et al. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (mono , 1999, Journal of immunology.
[50] G. Yu,et al. Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. , 1999, Journal of immunology.
[51] S. Rankin,et al. Mechanisms of Acute Eosinophil Mobilization from the Bone Marrow Stimulated by Interleukin 5: The Role of Specific Adhesion Molecules and Phosphatidylinositol 3-Kinase , 1998, The Journal of experimental medicine.
[52] C. Martínez-A,et al. The Coordinated Action of CC Chemokines in the Lung Orchestrates Allergic Inflammation and Airway Hyperresponsiveness , 1998, The Journal of experimental medicine.
[53] C. Mackay,et al. Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.
[54] F. Saulnier,et al. Bronchial neutrophilia in patients with noninfectious status asthmaticus. , 1998, American journal of respiratory and critical care medicine.
[55] A. Proudfoot,et al. The CC chemokine antagonist Met‐RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3 , 1997, European journal of immunology.
[56] C. Boshoff,et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. , 1997, Science.
[57] T. Schwartz,et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. , 1997, Science.
[58] C. Mackay,et al. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. , 1997, The Journal of clinical investigation.
[59] D. Davies,et al. The chemokines: their potential role in allergic inflammation , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[60] C. Mackay,et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils , 1996, The Journal of experimental medicine.
[61] J. Demartino,et al. Cloning, expression, and characterization of the human eosinophil eotaxin receptor , 1996, The Journal of experimental medicine.
[62] M. Montjovent,et al. Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*) , 1996, The Journal of Biological Chemistry.
[63] P. Murphy,et al. Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. , 1994, The Journal of biological chemistry.
[64] P. Barnes. New drugs for asthma , 2004, Nature Reviews Drug Discovery.
[65] S. Durham,et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.
[66] James J. Lee,et al. Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology. , 2003, American journal of physiology. Lung cellular and molecular physiology.